(Q37349788)

19 August 2017

1 reference

title

TGF-beta1 and Smad7 in the regulation of IBD. (English)

1 reference

19 August 2017

G Monteleone

1

1 reference

19 August 2017

M Boirivant

series ordinal

2

1 reference

19 August 2017

F Pallone

series ordinal

3

1 reference

19 August 2017

T T MacDonald

series ordinal

4

1 reference

19 August 2017

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

1 Suppl 1

1 reference

19 August 2017

S50-3

1 reference

https://scigraph.springernature.com/pub.10.1038/mi.2008.55

19 August 2017

0 references

cites work

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

The immunological and genetic basis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Transforming growth factor-beta in T-cell biology

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Inhibition of TGF-β Signaling by IL-15: A New Role for IL-15 in the Loss of Immune Homeostasis in Celiac Disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Smad7 in TGF-beta-mediated negative regulation of gut inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.55

7 January 2021

Identifiers

DOI

10.1038/MI.2008.55

1 reference

19 August 2017

1 reference